Frontlight ResearchEarly access
Trial site
CHU Nantes - Hôtel Dieu/Service d'Hématologie Clinique
- 2running trials
- 1closed trial
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Myelodysplastic syndromes2 trials
- Acute myeloid leukaemia1 trial
- Follicular lymphoma1 trial
- Phase
- Phase 22 trials
- Status
- Active, not recruiting1 trial
- Completed1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Groupe Francophone des Myelodysplasies2 trials
- The Lymphoma Academic Research Organisation1 trial
Running trials
Recruiting
Active, not recruiting
IDH2 (AG 221) Inhibitor in Patients With IDH2 Mutated Myelodysplastic Syndrome
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Myelodysplastic syndromes1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026